The present application claims the benefit under 35 U.S.C. § 371 of International Application No.: PCT/IN03/00317, filed Sep. 18, 2003, the entire contents of which is hereby incorporated herein by reference.
The present invention relates to a novel process for the preparation of tert-butyl 6-cyano-5-hydroxy-3-oxohexanoate, a key intermediate for the preparation of a HMG CoA reductase inhibitor.
HMG CoA reductase inhibitors are pharmaceutically active compounds used for inhibition of cholesterol biosynthesis. A group of compounds called ‘statins’ comprising lovastatin, simvastatin, mevastatin, pravastatin, atorvastatin, rosuvastatin, cerivastatin and fluvastatin show antilipidemic activity and are widely known HMG CoA reductase inhibitors.
The ester derivative of the compound of Formula I
is a valuable chiral synthon for synthesizing atorvastatin.
In one aspect, the present invention provides a novel process for the preparation of the compound of Formula I. In another aspect, the process employs novel intermediates.
The present invention relates to a novel process for preparing a compound of Formula I
comprising
The process of the present invention has several advantages over the prior art including: higher yield during conversion of the compound of Formula III to the compound of Formula II as the hydroxy group is protected, reactions after protection with TBDPS can be followed by TLC, low consumption of reagents as the hydroxy group is protected, and reduced levels of undesired side products.
In one aspect, the present invention provides a novel process for the preparation of a compound of Formula I
comprising
An exemplary process according to the present invention is depicted in Scheme I below:
wherein Alk is a straight or branched C1-C6 alkyl.
In one embodiment, the inventive process employs a hydroxy protecting group and utilizes novel intermediates of Formulae II and III. For example, TBDPS (tert-butyl diphenyl silyl) may be employed.
In certain exemplary embodiments, a compound of Formula I may be obtained by removal of the TBDPS group from a compound of Formula II by conventional methods.
In certain other embodiments, a compound of Formula II may be obtained by treating a compound of Formula III with a carbanion, which is generated by the reaction of tert-butyl acetate with lithium diisopropylamide.
In yet other embodiments, a compound of Formula III may be obtained by reacting a compound of Formula IV with tert-butyl diphenyl silyl chloride.
The illustrated embodiments have been set forth only for the purposes of example and should not be taken as limiting the invention. Therefore, it should be understood that, within the scope of the appended claims, the invention may be practiced other than specifically described herein.
Imidazole (6.5 g, 0.095 mol) was added to a chilled solution (−5 to −10° C.) of ethyl 4-cyano-3-hydroxybutanoate (10 g, 0.063 mol) in dichloromethane (100 ml) under stirring, followed by tert-butyl diphenyl silyl chloride (15.7 g, 0.057 mol). After stirring for 4 hours at room temperature, water (250 ml) was added to the reaction mixture and layers separated. The aqueous layer was extracted with dichloromethane (100 ml) and combined with the organic layer. The combined organic layer was evaporated to give title compound.
Yield: 22 g.
A solution of n-butyl lithium in hexane (14.4 ml, 0.21 mol) was added to a chilled solution (−5 to −10° C.) of diisopropylamlie (23.2 g, 0.23 mol) in THF (100 ml) and the resulting mixture was stirred at −5 to −10° C. for 30 minutes. After chilling the reaction to about −45° C., tert-butyl acetate (26 g, 0.21 mol) was added and the resulting reaction mixture was stirred at −20-30° C. for 1 hour. A solution of ethyl 4-cyano-3-(tert-butyldiphenylsilyloxy)-butanoate (20 g, 0.050 mol) in THF (20 ml) was added to the reaction mixture at about −75° C. and further stirred −70-−75° C. for 2 hours. Methanol (15 ml) was added to the reaction mixture followed by water (200 ml) and layers were separated. The organic layer was preserved. The aqueous layer was extracted with ethyl acetate (2×200 ml) and combined with the organic layer. The combined organic layer was evaporated to give the title compound.
Yield: 20 g.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IN03/00317 | 9/18/2003 | WO | 00 | 9/27/2004 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2005/026107 | 3/24/2005 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
5155251 | Butler et al. | Oct 1992 | A |
5216174 | Butler et al. | Jun 1993 | A |
6274740 | Lin et al. | Aug 2001 | B1 |
6528661 | Niddam et al. | Mar 2003 | B2 |
20020099224 | Niddam et al. | Jul 2002 | A1 |
20030114685 | Niddam-Hildesheim et al. | Jun 2003 | A1 |
20030175338 | Singh et al. | Sep 2003 | A1 |
Number | Date | Country |
---|---|---|
WO 9703960 | Feb 1997 | WO |
WO 0243667 | Jun 2002 | WO |
WO 03004450 | Jan 2003 | WO |
WO 03004455 | Jan 2003 | WO |
WO 03004456 | Jan 2003 | WO |
WO 03016317 | Feb 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20050065362 A1 | Mar 2005 | US |